Background To explore the potential mechanisms of SARS-CoV-2 in targeting the prostate
gland, leading to exacerbation of benign prostatic hyperplasia (BPH) symptoms and greater …

Due to late onset hypogonadism (LOH), there is an increased usage of testosterone
replacement therapy (TRT) in the aging male population. Since prostate is a target organ for …

Benign prostatic hyperplasia (BPH) as the leading cause of urination disorder is still a
refractory disease, and there have no satisfied drugs or treatment protocols yet. With …

Benign prostatic hyperplasia (BPH) is a common male condition that impacts many men's
quality of life by generating lower urinary tract symptoms (LUTS). In recent years …

Benign prostatic hyperplasia (BPH) is a chronic proliferative disease showing stromal-
dominant proliferation. However, the detailed proliferation mechanism has remained …

Autophagy is a highly conserved, lysosome-dependent biological mechanism involved in
the degradation and recycling of cellular components. There is growing evidence that …

Benign prostatic hyperplasia (BPH) is an age-related disorder, which is one of the most
prevalent and costly benign neoplasms in men with over 94 million cases worldwide …

Background: Benign prostatic hyperplasia (BPH) is the most common urogenital condition in
aging males, while inflammation and tissue proliferation constitute the main …

Aims In this study, we used a near-infrared laser (NIR) to increase the potency of silver
nanoparticles (AgNPs) to develop a novel, less invasive, and simple photothermal therapy …

Introduction Inflammation and infection are causative factors of benign prostatic hyperplasia
(BPH). Urine is not sterile, and urine microbiota identified by DNA sequencing can play an …